Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Narcolepsy01:07

Narcolepsy

Narcolepsy is a chronic sleep disorder characterized by pervasive, uncontrolled sleepiness and other sleep disturbances. One of its hallmark symptoms is an abrupt transition to REM sleep upon falling asleep, which causes symptoms typically associated with this phase to occur unexpectedly during wakefulness. These include the following symptoms, which typically last from a minute or two to half an hour.
Sleep-Wake Cycles01:24

Sleep-Wake Cycles

Sleep is an essential physiological process vital to maintaining overall well-being. The reticular activating system (RAS), a network of neurons in the brainstem, regulates wakefulness and sleep. While it may seem passive, sleep consists of distinct cycles, each with its unique characteristics and functions. Two key sleep phases are non-rapid eye movement (NREM) and  rapid eye movement (REM).
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
Understanding Sleep01:11

Understanding Sleep

Sleep, an essential biological state, involves significant reductions in physical activity, sensory awareness, and interaction with the environment. This complex physiological process is primarily regulated by specific brain regions, notably the hypothalamus and pons, which govern the sleep-wake cycle or circadian rhythm.
The circadian rhythm, a nearly 24-hour cycle, is deeply influenced by environmental light cues. Light exposure directly affects the hypothalamus, which in turn regulates...
REM Sleep Behavior Disorder01:15

REM Sleep Behavior Disorder

REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...
Management of Insomnia01:19

Management of Insomnia

The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
Nightmares and Night Terrors01:18

Nightmares and Night Terrors

Nightmares and night terrors represent two distinct types of sleep disturbances that differ in timing, characteristics, and the sleeper's recall of the event. Nightmares are vivid, disturbing dreams that usually awaken the sleeper from REM sleep, a stage of sleep where brain activity is high, and dreams are most frequent. Upon awakening, individuals often have detailed recollections of their nightmares, which can include themes of threats to survival, security, or self-esteem.
Nightmares often...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Enhancing the Health of NHS Staff: eTHOS-a randomised controlled pilot trial of an employee health screening clinic for NHS staff compared with usual care to reduce absenteeism and presenteeism.

Pilot and feasibility studies·2026
Same author

Psychosis in Huntington's disease: a review and comparison with schizophrenia.

Schizophrenia research·2025
Same author

Data-driven Huntington's disease progression modelling and estimation of societal cost in the UK.

Royal Society open science·2024
Same author

Health screening clinic to reduce absenteeism and presenteeism among NHS Staff: eTHOS a pilot RCT.

Health and social care delivery research·2024
Same author

Health state utility estimates for value assessments of novel treatments in Huntington's disease: a systematic literature review.

Health and quality of life outcomes·2024
Same author

An Overview of Specialist Services for Huntington's Disease in the United Kingdom.

Journal of Huntington's disease·2023
Same journal

Advances in the Application of Brain-Computer Interface-Based Neurofeedback Training in the Rehabilitation of Patients with Major Depressive Disorder.

Neuropsychiatric disease and treatment·2026
Same journal

Second-Generation Long-Acting Injectable Antipsychotics: A Comprehensive Assessment of Effectiveness, Safety, and Cost.

Neuropsychiatric disease and treatment·2026
Same journal

Resting-State EEG Characteristics of Tardive Dyskinesia: Spectral and Network Connectivity Insights.

Neuropsychiatric disease and treatment·2026
Same journal

Efficacy of Adjunctive Lumateperone 42 mg on Anhedonia and Across a Broad Range of Depressive Symptoms in Major Depressive Disorder: Post Hoc Analysis of a Phase 3, Randomized, Placebo-Controlled Trial.

Neuropsychiatric disease and treatment·2026
Same journal

Modifying Neuropsychiatric and Motor Trajectories in Huntington's Disease Through an Integrated Neurobehavioral Clinic Model.

Neuropsychiatric disease and treatment·2026
Same journal

Mini-Review: Allicin as a Potential Neuroprotective Compound in Neurological Disorders.

Neuropsychiatric disease and treatment·2026
See all related articles

Related Experiment Video

Updated: May 29, 2026

Polygraphic Recording Procedure for Measuring Sleep in Mice
08:45

Polygraphic Recording Procedure for Measuring Sleep in Mice

Published on: January 25, 2016

Narcolepsy: a review.

Gbolagade Sunmaila Akintomide1, Hugh Rickards

  • 1Department of Neuropsychiatry, University of Birmingham, Edgbaston, Birmingham, UK.

Neuropsychiatric Disease and Treatment
|September 21, 2011
PubMed
Summary
This summary is machine-generated.

Narcolepsy is a lifelong sleep disorder affecting 0.05% of the population. Current understanding points to hypocretin neuron loss in narcolepsy with cataplexy, with diagnosis based on symptoms and tests, and treatment involving medication and lifestyle changes.

Keywords:
cataplexygamma hydroxybutyratehypocretinmodafinilnarcolepsy

More Related Videos

Optogenetic Manipulation of Neural Circuits During Monitoring Sleep/wakefulness States in Mice
08:58

Optogenetic Manipulation of Neural Circuits During Monitoring Sleep/wakefulness States in Mice

Published on: June 19, 2019

Quantifying Infra-slow Dynamics of Spectral Power and Heart Rate in Sleeping Mice
10:56

Quantifying Infra-slow Dynamics of Spectral Power and Heart Rate in Sleeping Mice

Published on: August 2, 2017

Related Experiment Videos

Last Updated: May 29, 2026

Polygraphic Recording Procedure for Measuring Sleep in Mice
08:45

Polygraphic Recording Procedure for Measuring Sleep in Mice

Published on: January 25, 2016

Optogenetic Manipulation of Neural Circuits During Monitoring Sleep/wakefulness States in Mice
08:58

Optogenetic Manipulation of Neural Circuits During Monitoring Sleep/wakefulness States in Mice

Published on: June 19, 2019

Quantifying Infra-slow Dynamics of Spectral Power and Heart Rate in Sleeping Mice
10:56

Quantifying Infra-slow Dynamics of Spectral Power and Heart Rate in Sleeping Mice

Published on: August 2, 2017

Area of Science:

  • Neurology
  • Sleep Medicine
  • Genetics

Background:

  • Narcolepsy is a chronic neurological disorder impacting quality of life.
  • Characterized by excessive daytime sleepiness, cataplexy, hypnagogic hallucinations, and sleep paralysis.
  • Affects approximately 0.05% of the population.

Purpose of the Study:

  • To critically appraise the current evidence for diagnosing narcolepsy.
  • To review the established and emerging treatments for narcolepsy.
  • To explore the underlying pathogenesis of narcolepsy, particularly narcolepsy with cataplexy.

Main Methods:

  • Review of diagnostic criteria including symptom assessment, polysomnography, and hypocretin levels.
  • Evaluation of current pharmacological and non-pharmacological treatment strategies.
  • Analysis of research on the genetic predisposition and neurobiological basis of narcolepsy.

Main Results:

  • Narcolepsy with cataplexy is linked to the loss of hypothalamic hypocretin neurons in genetically susceptible individuals (HLA-DQB1*0602 positive).
  • Diagnosis relies on a combination of clinical presentation, sleep studies, and biochemical markers.
  • Current management focuses on symptom control through medication and lifestyle adjustments, with ongoing research into novel therapies.

Conclusions:

  • Narcolepsy is a complex disorder with significant impact on patients' lives.
  • Understanding the role of hypocretin and genetic factors is crucial for diagnosis and future treatments.
  • While no cure exists, evidence-based diagnosis and management strategies can improve patient outcomes.